Unicycive Therapeutics, Inc. (UNCY)
4.80
+0.03
(+0.63%)
USD |
NASDAQ |
Sep 18, 16:00
4.805
0.00 (0.00%)
After-Hours: 20:00
Unicycive Therapeutics Total Return Level : 4.80 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 4.80 |
| September 17, 2026 | 4.77 |
| September 16, 2026 | 4.78 |
| September 15, 2026 | 4.71 |
| September 14, 2026 | 5.15 |
| September 11, 2026 | 5.29 |
| September 10, 2026 | 5.31 |
| September 09, 2026 | 5.12 |
| September 08, 2026 | 5.03 |
| September 04, 2026 | 5.16 |
| September 03, 2026 | 5.30 |
| September 02, 2026 | 5.19 |
| September 01, 2026 | 5.05 |
| August 31, 2026 | 5.20 |
| August 28, 2026 | 5.265 |
| August 27, 2026 | 5.50 |
| August 26, 2026 | 5.43 |
| August 25, 2026 | 5.47 |
| August 24, 2026 | 5.34 |
| August 21, 2026 | 5.63 |
| August 20, 2026 | 5.45 |
| August 19, 2026 | 5.58 |
| August 18, 2026 | 5.63 |
| August 17, 2026 | 5.57 |
| August 14, 2026 | 5.51 |
| Date | Value |
|---|---|
| August 13, 2026 | 5.40 |
| August 12, 2026 | 5.39 |
| August 11, 2026 | 5.00 |
| August 10, 2026 | 5.02 |
| August 07, 2026 | 5.07 |
| August 06, 2026 | 5.05 |
| August 05, 2026 | 5.23 |
| August 04, 2026 | 5.17 |
| August 03, 2026 | 5.055 |
| July 31, 2026 | 5.01 |
| July 30, 2026 | 5.30 |
| July 29, 2026 | 4.74 |
| July 28, 2026 | 4.94 |
| July 27, 2026 | 5.13 |
| July 24, 2026 | 5.40 |
| July 23, 2026 | 5.46 |
| July 22, 2026 | 5.57 |
| July 21, 2026 | 5.69 |
| July 20, 2026 | 5.45 |
| July 17, 2026 | 5.38 |
| July 16, 2026 | 5.05 |
| July 15, 2026 | 5.02 |
| July 14, 2026 | 5.22 |
| July 13, 2026 | 5.09 |
| July 10, 2026 | 5.21 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 454.67 |
| Decoy Therapeutics, Inc. | 2.78 |
| Nuvectis Pharma, Inc. | 22.00 |
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |